PortugalPortugal

Price for two biotechs

16.05.2007

Porto – Two Portuguese biotech companies have won the national idea contest for bio-entrepreneurs (Concurso de Ideias Bioempreendedor 2006), organized every year by the Portuguese Association of Bioindustries (APBio) and the government agency, the Institute for the Support of Small and Medium-sized Enterprises (IAPMEI)
At the end of April, Infogene, a spin-off from the Institute Pedro Nunes at Coimbra, and Gene Predit Lda, a biotech start-up located in the Biocant incubator at Catanede since its foundation last year, each received the prize money of a5,000.
Gene Predit focuses on biomarker identification and screening for pharmaceutical compounds for these new targets. For these purposes, the company relies on comparative in-silico- and in-vivo genomics.
Infogene puts its focus on genetic studies in the area of cancer. The company has developed a non invasive home-brew test for the detection of the Human Papilloma Virus (HPV), the most common cause of cervical cancer, and a test for detection of colorectal and uterus cancer. The alternative to the common Pap test for HP-Virus detection will be launched this September, according to the company.

PortugalPortugal

02.12.2011

Lisbon – Genetically modified organisms (GMOs) are gaining ground in southwestern Europe. According to the European Association for Bioindustries (EuropaBio), Portuguese farmers planted nearly 60% more genetically modified maize...

PortugalPortugal

07.10.2011

Lisbon – In the southwest of Europe, GMOs are gaining ground. According to the European Association for BioIndustries EuropaBio, Portuguese farmers have grown nearly 60% more genetically modified (GM) maize this year compared to...

PortugalPortugal

11.08.2011

Lisbon – According to a report published by business intelligence provider Espicom, the future for biopharma on the westernmost tip of Europe looks anything but sunny. Its analysts predict that by 2016, the pharmaceuticals market...

PortugalPortugal

08.03.2010

Lisbon – Portugal’s “Fundação para a Ciência e Tecnologia” (FCT) is to channel funding into collaborations between Portuguese and Indian life science companies and research within the networking pilot programme “New Indigo”...

PortugalPortugal

14.09.2009

Coimbra/San Francisco/Munster – Portuguese and US researchers have discovered a new factor that determines whether an embryonic stem cell (ESC) will remain pluripotent or not. After the team under Miguel and Joao Ramalho-Santos...

PortugalPortugal

12.07.2009

Madrid –The Spanish Ministry of Health is investing in future biotech treatments. In July, it signed a EUR60m contract over a recombinantly manufactured flu vaccine developed by Rockville-based Novavax. In Phase II trials, the...

09.05.2009

Lisbon/New York - A Portuguese-US research team has discovered a new molecular mechanism that enables gamma herpes viruses to chronically infect patients. Gamma herpes viruses infect white blood cells (B- or T-lymphocytes)...

PortugalPortugal

21.02.2009

Lisbon – Portugal’s Bial SA has granted American company Sepracor the exclusive rights to develop and commercialise eslicarbazepine in the United States and Canada. Bial will receive US$57m up front.

Displaying results 1 to 10 out of 37

1-10 Next >

© 2007-2016 BIOCOM

http://www.european-biotechnology-news.com/news/messages-archive/archive-portugal/article/price-for-two-biotechs.html

Whitepaper

Current issue

All issues

Product of the week

Products

Job Advert

Researchers

As a company at the leading edge of genomics, the focus at Illumina is research and development. We take our employees seriously. From colleagues to career path to meeting professional goals, we help you find opportunities to grow your career. more...

Video

All videos

Stock list

All quotes

TOP

  • SAREUM HOLDINGS (UK)0.28 GBP12.00%
  • IXICO (UK)35.50 GBP4.41%
  • SUMMIT (UK)4.03 GBP3.87%

FLOP

  • SWEDISH ORPHAN BIOVITRUM (S)12.45 USD-23.38%
  • BIOTIE THERAPEUTICS (FI)0.14 EUR-22.22%
  • THERAMETRICS (CH)0.04 CHF-20.00%

TOP

  • VERONA PHARMA (UK)3.25 GBP22.6%
  • IXICO (UK)35.50 GBP20.3%
  • SERODUS (N)2.55 NOK10.9%

FLOP

  • BIONOR PHARMA (N)0.80 NOK-53.5%
  • PROTHENA PLC (IE)30.94 USD-36.1%
  • ZEALAND PHARMA (DK)92.50 DKK-34.6%

TOP

  • CHRONTECH PHARMA (S)0.34 SEK3300.0%
  • KARO BIO (S)24.00 SEK3016.9%
  • 4SC (D)3.04 EUR261.9%

FLOP

  • BIOTEST (D)11.91 EUR-87.1%
  • NEUROVIVE PHARMACEUTICAL AB (S)8.70 SEK-85.7%
  • EVOCUTIS (UK)0.08 GBP-71.4%

No liability assumed, Date: 10.02.2016

Events

All Events